Stryker Agrees to $1.4 Billion Hip Implant Settlement
Posted in Drug & Medical Devices on November 12, 2014
Stryker has agreed to compensate thousands of individuals affected by recalled hip implants—setting aside $1.4 billion to cover costs of the settlement. The affected implants are the ABG II Modular Hip System and the Rejuvenate Modular Hip System. Bloomberg news reports the medical device manufacturer “will pay a base amount of $300,000 per case...
Stryker reverses course on hip systems, recommends patients get checked
Posted in Drug & Medical Devices on January 22, 2013
By Arthur Elk More than six months after recalling two popular modular hip systems, Stryker is telling any patients with the hips in their bodies to visit their doctor and get tested. In June 2012, the company issued a voluntary recall of its Rejuvenate and ABG II modular hip systems. The company made the...
Ohio Product Defect Lawyers: FDA restricts use of Stryker brain stent
Posted in Drug & Medical Devices on August 10, 2012
The FDA has restricted the use of the Wingspan brain stent after evidence surfaced that the device may increase the risk of stroke and death. The Ohio medical malpractice lawyers of Elk & Elk want to make you aware of the possible danger involved in using these stents. The U.S. Food and Drug Administration...